New aspects of diagnosis and management of patients with drug-induced headache
| Autor: | V. А. Golovacheva, V. V. Osipova |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2013 |
| Předmět: | |
| Zdroj: | Медицинский совет, Vol 0, Iss 12, Pp 14-19 (2013) |
| Druh dokumentu: | article |
| ISSN: | 2079-701X 2658-5790 |
| DOI: | 10.21518/2079-701X-2013-12-14-19 |
| Popis: | Medication-induced headache is a cephalgia continuing for 15 days or more per month for more than 3 months, and associated with regular excessive use of drugs for the symptomatic treatment of headache. Drug-induced headache develops in patients with a primary form of cephalgia, usually migraine or tension-type headache. Diagnosis of drug-induced headache is clinical, i.e. based on the complaints, history and diagnostic criteria of the International Classification of Headache Disorders. ICBG-3 beta was published in July 2013 which introduced the new criteria for drug-induced headache. The treatment includes behavioral therapy, withdrawal of the medication which induced headache, detoxification, if necessary, management of symptoms associated with withdrawal, and individual preventive treatment of the underlying headache. There is an overview of literature on the methods of treatment of drug-induced headache. Risks, causes of relapse and predictors of treatment failure are described. Focus is on Ketonal (ketoprofen) which is effective in relieving tension headaches and migraine prevention. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|